Asmaa Soliman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Asmaa Soliman has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Abdelrhman H. Mohamed
Faculty of Medicine, Luxor University, Luxor, Egypt
2 shared publications - Amr Khalid Abdallah
Faculty of Medicine, Menofia University, Menofia, Egypt
2 shared publications - Bahaa Elfakharany
Radiation Therapy Department, Baheya Hospital, Giza, Egypt
2 shared publications - Basma M. El-Khalifa
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2 shared publications - Eman Ayman Nada
Faculty of Pharmacy, Tanta University, Gharbia, Egypt
2 shared publications - Fatma A. Rikabe
Al-Thaqalyn Cancer Hospital, Department of Radiotherapy
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1) , 611
Analgesic efficacy of uni-level erector spinae plane block in breast cancer surgery patients: a systematic review and Meta-analysis
- 12 October 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1) , 611
Open AccessAnalgesic efficacy of uni-level erector spinae plane block in breast cancer surgery patients: a systematic review and Meta-analysis
- Open Access
- 25 September 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
Indocyanine green-guided lymphadenectomy in gastrectomy for gastric cancer: a systematic review and meta-analysis with trial sequential analysis and meta-regression
Background: Indocyanine green (ICG) near-infrared fluorescence is increasingly used to guide lymphadenectomy during laparoscopic gastrectomy for gastric cancer, but its impact on oncologic outcomes and perioperative safety compared with conventional surgery remains unclear. This systematic review and meta-analysis evaluates whether ICG guidance improves long-term outcomes and surgical quality in adults undergoing laparoscopic radical gastrectomy for resectable gastric adenocarcinoma. Methods: We systematically searched PubMed, Scopus, Web of Science, and the Cochrane Library through October 2025 for randomized trials and comparative cohort studies comparing ICG-guided lymphadenectomy with conventional laparoscopic gastrectomy without ICG. Random-effects models were used to pool effect estimates, with subgroup analyses, meta-regression, sensitivity analyses, and trial sequential analysis employed to explore heterogeneity and assess robustness. Results: From 1457 records, 28 studies were included, of which 25 contributed to the meta-analysis. ICG guidance significantly increased total lymph node retrieval [mean difference (MD): 6.57 nodes; 95% confidence interval (CI): 5.09–8.04; P < 0.0001] without increasing metastatic lymph node yield (MD: 0.01; 95% CI: −0.53 to 0.56; P = 0.958). No significant differences emerged in 5-year overall survival [risk ratio (RR): 0.99; 95% CI: 0.87–1.12], 2-year overall survival (RR: 1.03; 95% CI: 0.95–1.12), or 30-day mortality (RR: 1.19; 95% CI: 0.34–4.25). ICG-guided surgery showed modest reductions in operative time (MD: −8.67 min), blood loss (MD: −11.84 mL), and hospital stay (MD: −0.54 days), though heterogeneity was substantial for several perioperative outcomes. No significant reductions were seen in overall complications, Clavien–Dindo grade-specific complications, time to first flatus or oral intake or affected resection margins. Conclusion: ICG fluorescence–guided lymphadenectomy provides meaningful technical benefits during laparoscopic gastrectomy, increasing lymph node yield and modestly improving perioperative efficiency without compromising survival or increasing harm. These findings support ICG as a safe, effective adjunct to standard gastrectomy, though standardized protocols and further large, high-quality trials are needed to confirm long-term oncologic benefit.
- 25 September 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
Open AccessIndocyanine green-guided lymphadenectomy in gastrectomy for gastric cancer: a systematic review and meta-analysis with trial sequential analysis and meta-regression
Background: Indocyanine green (ICG) near-infrared fluorescence is increasingly used to guide lymphadenectomy during laparoscopic gastrectomy for gastric cancer, but its impact on oncologic outcomes and perioperative safety compared with conventional surgery remains unclear. This systematic review and meta-analysis evaluates whether ICG guidance improves long-term outcomes and surgical quality in adults undergoing laparoscopic radical gastrectomy for resectable gastric adenocarcinoma. Methods: We systematically searched PubMed, Scopus, Web of Science, and the Cochrane Library through October 2025 for randomized trials and comparative cohort studies comparing ICG-guided lymphadenectomy with conventional laparoscopic gastrectomy without ICG. Random-effects models were used to pool effect estimates, with subgroup analyses, meta-regression, sensitivity analyses, and trial sequential analysis employed to explore heterogeneity and assess robustness. Results: From 1457 records, 28 studies were included, of which 25 contributed to the meta-analysis. ICG guidance significantly increased total lymph node retrieval [mean difference (MD): 6.57 nodes; 95% confidence interval (CI): 5.09–8.04; P < 0.0001] without increasing metastatic lymph node yield (MD: 0.01; 95% CI: −0.53 to 0.56; P = 0.958). No significant differences emerged in 5-year overall survival [risk ratio (RR): 0.99; 95% CI: 0.87–1.12], 2-year overall survival (RR: 1.03; 95% CI: 0.95–1.12), or 30-day mortality (RR: 1.19; 95% CI: 0.34–4.25). ICG-guided surgery showed modest reductions in operative time (MD: −8.67 min), blood loss (MD: −11.84 mL), and hospital stay (MD: −0.54 days), though heterogeneity was substantial for several perioperative outcomes. No significant reductions were seen in overall complications, Clavien–Dindo grade-specific complications, time to first flatus or oral intake or affected resection margins. Conclusion: ICG fluorescence–guided lymphadenectomy provides meaningful technical benefits during laparoscopic gastrectomy, increasing lymph node yield and modestly improving perioperative efficiency without compromising survival or increasing harm. These findings support ICG as a safe, effective adjunct to standard gastrectomy, though standardized protocols and further large, high-quality trials are needed to confirm long-term oncologic benefit.
- Open Access
- 24 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes With Meta-Regression
From the 8th International Cancer Congress
- 24 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessEnfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes With Meta-Regression
From the 8th International Cancer Congress
- Open Access
- 22 August 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1) , 344
Erector spinae plane block (ESPB) versus paravertebral plane block (PVB) in managing post-operative pain in breast cancer patients: a systematic review and meta-analysis
- 22 August 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1) , 344
Open AccessErector spinae plane block (ESPB) versus paravertebral plane block (PVB) in managing post-operative pain in breast cancer patients: a systematic review and meta-analysis
- Open Access
- 22 May 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Perioperative and short-term oncological outcomes of laparoscopic versus open pancreaticoduodenectomy: an updated systematic review and meta-analysis of randomized controlled trials with GRADE evaluation
Surgical resection through pancreatoduodenectomy (PD) represents the only curative option for periampullary and pancreatic head tumors. Recently, laparoscopic pancreatoduodenectomy (LPD) has emerged as a minimally invasive alternative to the open approach (OPD). However, the safety, feasibility, and short-term oncologic adequacy of LPD compared to OPD remain a matter of controversy. This systematic review and meta-analysis aimed to compare perioperative and short-term oncologic outcomes of LPD versus OPD in patients with periampullary and pancreatic head primaries. A comprehensive literature search was performed in PubMed, Scopus, and Web of Science databases for RCTs comparing LPD and OPD in adult periampullary tumor patients. Key outcomes analyzed included operative time, blood loss, hospital length of stay, complications, mortality, and lymph node harvest. Risk of bias was assessed using the Cochrane RoB-2 tool, and the certainty of evidence was graded via GRADE. Seven RCTs were included, revealing that LPD is associated with longer operative times (MD~50.90 min) but significantly reduced blood loss (MD-88.83 mL), shorter hospital stays (MD-1.33 days), and fewer transfusions (RR 0.75). No significant differences were observed in 90-day mortality, overall or severe complications, lymph node retrieval, or R0 resection rates. The GRADE rating was high for clinically relevant gastric emptying, and moderate or low certainty for most other outcomes. LPD provides statistically significant perioperative advantages without compromising oncological outcomes, suggesting it is a safe and effective alternative to OPD in experienced centers.
- 22 May 2026
- Published by Springer Nature in BMC Surgery
- Vol. 26 (1)
Open AccessPerioperative and short-term oncological outcomes of laparoscopic versus open pancreaticoduodenectomy: an updated systematic review and meta-analysis of randomized controlled trials with GRADE evaluation
Surgical resection through pancreatoduodenectomy (PD) represents the only curative option for periampullary and pancreatic head tumors. Recently, laparoscopic pancreatoduodenectomy (LPD) has emerged as a minimally invasive alternative to the open approach (OPD). However, the safety, feasibility, and short-term oncologic adequacy of LPD compared to OPD remain a matter of controversy. This systematic review and meta-analysis aimed to compare perioperative and short-term oncologic outcomes of LPD versus OPD in patients with periampullary and pancreatic head primaries. A comprehensive literature search was performed in PubMed, Scopus, and Web of Science databases for RCTs comparing LPD and OPD in adult periampullary tumor patients. Key outcomes analyzed included operative time, blood loss, hospital length of stay, complications, mortality, and lymph node harvest. Risk of bias was assessed using the Cochrane RoB-2 tool, and the certainty of evidence was graded via GRADE. Seven RCTs were included, revealing that LPD is associated with longer operative times (MD~50.90 min) but significantly reduced blood loss (MD-88.83 mL), shorter hospital stays (MD-1.33 days), and fewer transfusions (RR 0.75). No significant differences were observed in 90-day mortality, overall or severe complications, lymph node retrieval, or R0 resection rates. The GRADE rating was high for clinically relevant gastric emptying, and moderate or low certainty for most other outcomes. LPD provides statistically significant perioperative advantages without compromising oncological outcomes, suggesting it is a safe and effective alternative to OPD in experienced centers.